COMMUNIQUÉS West-GlobeNewswire

Y-mAbs Secures Commercial Radiolabeling Capacity
01/07/2019
NEW YORK, July 01, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
PCI Biotech to present at IPA World Congress
01/07/2019
Oslo, Norway, July 1, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the company at the [...]
Novo Nordisk A/S - Share repurchase programme
01/07/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 1 July 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European [...]
SubioMed™ Bolsters Management With Appointment of Janine Whited as Controller
01/07/2019
Joins Company Comprised of a Team of Accomplished Executives and Industry Veterans Focused on Patented Inventions by Dr. Barry Butler, DPM Practicing Podiatrist and Serial Inventor MINNEAPOLIS, July 01, 2019 (GLOBE [...]
Checkpoint Therapeutics Added to Russell 2000® Index
01/07/2019
NEW YORK, July 01, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Cytori Reports Summary of FDA Feedback Regarding its ATI-1123 Product
01/07/2019
AUSTIN, Texas, July 01, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) today provided an update on the development of its proprietary drug, ATI-1123, based on recently obtained feedback from the [...]
PSIQ and Ecoland Agree to Extension
01/07/2019
SUNRISE, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Grey: PSIQ) is pleased to announce an extension of the letter of intent to acquire 80% of Ecoland K.K.L. LTD and Ecoland USA SF INC [...]
Medovex Corporation Updates Name Change and Full Rebranding to H-CYTE
01/07/2019
TAMPA, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today updated investors on its name change and rebranding to H-CYTE. The announcement underscores the Company's broader commitment focusing on [...]
EY Names Tim Herbert, President & CEO of Inspire Medical Systems, Inc., Entrepreneur Of The Year® 2019 Award Winner in the Heartland
01/07/2019
MINNEAPOLIS, July 01, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
PhaseBio Added to Russell 2000® and 3000® Indexes
01/07/2019
MALVERN, Pa., and SAN DIEGO, Calif., July 01, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]
Spring Bank Submits IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors
01/07/2019
HOPKINTON, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
aTyr Pharma Strengthens Board of Directors with the Appointment of Two New Members
01/07/2019
SAN DIEGO, July 01, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today [...]
VBI Vaccines Added to Russell 2000® and Russell 3000® Indexes
01/07/2019
CAMBRIDGE, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Catalyst Biosciences Announces Oral and Poster Presentations at the International Society on Thrombosis and Haemostasis
01/07/2019
Oral presentation of the final Phase 2 trial data of MarzAA for the treatment of hemophilia A or B with inhibitors Company to host investor call and webcast on Monday, July 8 at 8:00 a.m. EDT SOUTH SAN FRANCISCO, Calif [...]
HempAmericana Adds High-Capacity Solvent Recovery System ahead of Company’s Commercial Distribution
01/07/2019
NEW YORK, July 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is excited to announce the purchase and [...]
BioSig Technologies, Inc. Added to Membership of Russell 3000® Index
01/07/2019
Santa Monica, CA, July 01, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Strongbridge Biopharma plc Added to the Russell 3000® and Microcap® Indexes
01/07/2019
DUBLIN, Ireland and TREVOSE, Pa., July 01, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Organogenesis Joins Russell 2000®, Russell 3000® and Russell Microcap® Indexes
01/07/2019
CANTON, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for [...]
Biogen Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients
01/07/2019
New results from the NURTURE study demonstrate that pre-symptomatic infants treated with SPINRAZA are achieving motor milestones that are unprecedented in the natural history of the disease, including 100 percent of [...]

Pages